Clinical Features Assessment and Effect of Olfactory Training among COVID-19 Patients in the Kingdom of Saudi Arabia
DOI:
https://doi.org/10.14738/aivp.106.13486Keywords:
COVID-19 Symptoms; Anosmia; Hyposmia; Smell training; Essential oils; Epidemiology.Abstract
Coronavirus disease (COVID-19) was announced in Mar 2020 as a global pandemic. Olfactory dysfunction (OD) is a common consequence. Therefore, the present study assessed the prevalence of OD and other clinical features among COVID-19 patients in Saudi Arabia along with the effect of olfactory training. Eighty-two patients participated in this study and their demographics as well as clinical features, effect of olfactory training, and recovery time were assessed using a questionnaire. Patients with OD went through self olfactory training by sniffing essential oils twice a day for 30 or 40 sec, followed by 10 or 20 sec break then repeat for 5 or 10 min for 6 weeks. Our results revealed that 62% had OD in which 41% had hyposmia and 21% had anosmia, while 38% had normosia. Additionally, 80% lost their olfactory function during infection period, whereas 20% lost it post-infection. Most patients recovered their olfactory function after 2 weeks (39%). Moreover, 71% restored their olfactory function naturally, whilst 27% restored it by olfactory training, and 2% did not experience improvement. The frequently reported symptoms among OD patients included headache (62%), sore throat (60%), fever (54%), and cough (48%). Whereas the common symptoms among patients without OD are bone pain (38%), diarrhea (24%) anorexia (21%), and vomiting (11%). This study highlights the prevalence and underlying mechanism of OD and the potential effect of olfactory training using essential oils due to their unharmful bioactive molecules. The likely of OD makes it a recommended diagnostic tool in early COVID-19 stage.
References
WHO. COVID-19 Dashboard [Internet]. 2022 [cited 2022 Apr 16];Available from: https://covid19.who.int/
WHO. Saudi Arabia Situation [Internet]. 2022 [cited 2022 Apr 16];Available from: https://covid19.who.int/region/emro/country/sa
Sharma A, Ahmad Farouk I, Lal SK. Covid-19: A review on the novel coronavirus disease evolution, transmission, detection, control and prevention. Viruses 2021;13:1–25. https://doi.org/10.3390/v13020202
Naqvi AAT, Fatima K, Mohammad T, Fatima U, Singh IK, Singh A, et al. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim. Biophys. Acta - Mol. Basis Dis. [Internet] 2020;1866:165878. Available from: https://doi.org/10.1016/j.bbadis.2020.165878
Seo MY, Choi WS, Lee SH. Clinical Features of Olfactory Dysfunction in COVID-19 Patients. J. Korean Med. Sci. 2021;36:1–9. https://doi.org/10.3346/JKMS.2021.36.E161
Whitcroft KL, Hummel T. Olfactory Dysfunction in COVID-19: Diagnosis and Management. JAMA - J. Am. Med. Assoc. 2020;323:2512–4. https://doi.org/10.1001/jama.2020.8391
Huart C, Philpott C, Konstantinidis I, Altundag A, Whitcroft KL, Trecca EMC, et al. Comparison of COVID-19 and common cold chemosensory dysfunction. Rhinology 2020;58:1–3. https://doi.org/10.4193/Rhin20.251
Mao Y, Ye B, Fan C, Wu J, Wang B, Shen Y, et al. Correlation Between Coronavirus Disease 2019 and Olfactory Dysfunction. Front. Public Heal. 2022;10:1–8. https://doi.org/10.3389/fpubh.2022.843850
Desai M, Oppenheimer J. The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice. J. Allergy Clin. Immunol. Pract. [Internet] 2021;9:7–12. Available from: https://doi.org/10.1016/j.jaip.2020.10.036
Goncalves S, Goldstein B. Pathophysiology of Olfactory Disorders and Potential Treatment Strategies. Curr. Otorhinolaryngol. Rep. 2017;4:115–21. https://doi.org/10.1007/s40136-016-0113-5
Hummel T, Reden KRJ, Hähner A, Weidenbecher M, Hüttenbrink KB. Effects of olfactory Training in patients with olfactory loss. Laryngoscope 2009;119:496–9. https://doi.org/10.1002/lary.20101
Alroqi A, Alothaim L, Albugami S, Alothaim N, Alqabbani A, Alromaih S, et al. Smell Disturbance among Saudi COVID-19 Patients. J. Nat. Sci. Med. 2021;4:348–51. https://www.researchgate.net/publication/353830033
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Oto-Rhino-Laryngology [Internet] 2020;277:2251–61. Available from: https://doi.org/10.1007/s00405-020-05965-1
Sorokowski P, Karwowski M, Misiak M, Marczak MK, Dziekan M, Hummel T, et al. Sex differences in human olfaction: A meta-analysis. Front. Psychol. 2019;10:1–9. https://doi.org/10.3389/fpsyg.2019.00242
Alqurashi S, Mandoura N. Smell and Taste Dysfunctions in Patients with Coronavirus Disease (COVID-19) Infection in Jeddah, Kingdom of Saudi Arabia: An Analytical Cross-Sectional Study. Int. J. Med. Res. Heal. Sci. [Internet] 2021;10:55–62. Available from: https://www.researchgate.net/publication/353830033
Li W, Li M, Ou G. COVID-19, cilia, and smell. FEBS J. 2020;287:3672–6. https://doi.org/10.1111/febs.15491
Torabi A, Mohammadbagheri E, Akbari Dilmaghani N, Bayat AH, Fathi M, Vakili K, et al. Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia. ACS Chem. Neurosci. 2020;11:1909–13. https://doi.org/10.1021/acschemneuro.0c00249
Butowt R, von Bartheld CS. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. Neuroscientist 2021;27:582–603. https://doi.org/10.1177/1073858420956905
Brann JH, Firestein SJ. A lifetime of neurogenesis in the olfactory system. Front. Neurosci. 2014;8:1–11. https://doi.org/10.3389/fnins.2014.00182
Liang F. Sustentacular cell enwrapment of olfactory receptor neuronal dendrites: An update. Genes (Basel). 2020;11:14–7. https://doi.org/10.3390/genes11050493
Cazzolla AP, Lovero R, Lo Muzio L, Testa NF, Schirinzi A, Palmieri G, et al. Taste and smell disorders in COVID-19 patients: Role of interleukin-6. ACS Chem. Neurosci. 2020;11:2774–81. https://doi.org/10.1021/acschemneuro.0c00447
Takayama S, Arita R, Ono R, Saito N, Suzuki S, Kikuchi A, et al. Treatment of covid-19-related olfactory disorder promoted by kakkontokasenkyushin’i: A case series. Tohoku J. Exp. Med. 2021;254:71–80. https://doi.org/10.1620/tjem.254.71
Koyama S, Kondo K, Ueha R, Kashiwadani H, Heinbockel T. Possible use of phytochemicals for recovery from covid-19-induced anosmia and ageusia. Int. J. Mol. Sci. 2021;22. https://doi.org/10.3390/ijms22168912
Mubaraki AA, Alrbaiai GT, Sibyani AK, Alhulayfi RM, Alzaidi RS, Almalki HS. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia. Saudi Med. J. 2021;42:38–43. https://doi.org/10.15537/SMJ.2021.1.25588
Klopfenstein T, Kadiane-oussou NJ, Toko L, Royer P, Lepiller Q, Gendrin V. Features of Anosmia in COVID-19. Médecine Mal. Infect. 2020;50:436–9. https://doi.org/10.1016/j.medmal.2020.04.006
Widyadharma IPE, Sari NNSP, Pradnyaswari KE, Yuwana KT, Adikarya IPGD, Tertia C, et al. Pain as clinical manifestations of COVID-19 infection and its management in the pandemic era: a literature review. Egypt. J. Neurol. Psychiatry Neurosurg. 2020;56. https://doi.org/10.1186/s41983-020-00258-0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Tahani Fahad Almutairi, Noorah Saleh Al-Sowayan
This work is licensed under a Creative Commons Attribution 4.0 International License.
